Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Scientific (CORZ) EPS (Weighted Average and Diluted) (2020 - 2026)

Core Scientific has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at -$1.06 for Q1 2026.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$1.06 for Q1 2026, down 185.48% from a year ago — trailing twelve months through Mar 2026 was -$0.95 (up 83.25% YoY), and the annual figure for FY2025 was -$0.88, up 81.93%.
  • EPS (Weighted Average and Diluted) reached -$1.06 in Q1 2026 per CORZ's latest filing, down from $0.6 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.24 in Q1 2025 and bottomed at -$5.05 in Q2 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.52 (2023), compared with a mean of -$0.74.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 76356.98% in 2024, while the deepest fall reached 25150.0% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.92 in 2022, then surged by 43.48% to -$0.52 in 2023, then plummeted by 32.69% to -$0.69 in 2024, then surged by 186.96% to $0.6 in 2025, then plummeted by 276.67% to -$1.06 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CORZ at -$1.06 in Q1 2026, $0.6 in Q4 2025, and -$0.45 in Q3 2025.